For Employers
Metabolic health solutions for your people
Our metabolic health benefit combines Digital Twin™ technology with clinical care to address the root cause of type 2 diabetes, obesity, prediabetes, and much more.
Trusted by leading companies
.png)
Real results for real people
Our outcomes aren’t just clinical — they’re human. With better metabolic health, members wake up with more energy, play with their kids or grandkids a little longer, and enjoy a weekend getaway without packing their meds.
73%
eliminated medications
(including injections)
-14 lbs
lost in 6 months
-2.2
point drop in A1C
70%
reduced inflammation
77%
improved insulin resistance
(in those with type 2 diabetes)
67%
reduced visceral fat
Twin’s commercial population, members 365+ days in program. Data as of September 2024.
The key to healing chronic conditions
Metabolic issues like inflammation and insulin resistance are behind many chronic health conditions. By working with a member’s unique metabolism, Twin Health’s programs address and improve many of the symptoms of metabolic conditions:
Hypertension
Inflammation
Insomnia
Fatigue
Chronic aches & pains
Immune function
Insulin resistance
Reliance on medications
Visceral fat
What our partners are saying
The highlight for us has been the flexibility....but more importantly the clinical integrity of your product and services.
Chief Clinical Officer at Leading Global Investment Firm
Twin has been excellent to work with to deliver cost-effective solutions.
Sr. Benefits Leader at Diversified Holdings Company
Twin members continue to lose weight after stopping GLP-1s
1. Based on the semaglutide (Ozempic) clinical trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542252/#dom14725-supitem-0001) N=228
2. Inclusive of Active Commercial Members >=52 weeks in the Twin T2D Program who stopped GLP-1 >=52 weeks prior to the analysis and had a start BMI >=27
Twin members continue losing weight after stopping GLP-1s
Twin members2
continue to lose ~6% of body weight on average
Patients without Twin
gain back ~13%
1. Based on the semaglutide (Ozempic) clinical trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542252/#dom14725-supitem-0001) N=228
2. Inclusive of Active Commercial Members >=52 weeks in the Twin T2D Program who stopped GLP-1 >=52 weeks prior to the analysis and had a start BMI >=27
Validated by clinical research
We stand behind our solutions
We’re so confident in the efficacy of our programs that our metabolic health benefits are offered fully at-risk. These programs are based upon the highest quality RCT research, which has been peer-reviewed and published in leading journals.
*Outcomes from a Twin self-insured employer partner
19%
Eligible population activated
within the first year
$8.4k
Annual savings per member
with at least one high-cost medication
$3.2M
Projected pharmacy savings
annualized across all members with 1 or more high-cost meds*
Transform employee health with proven results
See how Twin Health’s evidence-based, outcomes-driven programs empower your workforce to thrive—all with a risk-free, performance-based model. Contact us today to learn more.
